Table 3 Clinicopathologic features and hDAB2IP promoter methylation in gastric cancer
Clinicopathologic features | Variable a | Frequency of hDAB2IP m2a methylation (%) | P -value b | Frequency of hDAB2IP m2b methylation (%) | P -value b |
|---|---|---|---|---|---|
Sex | Male (n=21) | 8 (38) | 0.27 | 9 (43) | >0.99 |
Female (n=14) | 8 (57) | 6 (43) | |||
Tumour invasion | T1, 2 (n=20) | 9 (45) | 0.92 | 9 (45) | 0.77 |
T3, 4 (n=15) | 7 (47) | 6 (40) | |||
Nodal metastasis | N0 (n=14) | 7 (50) | 0.68 | 7 (50) | 0.49 |
N1, 2 (n=21) | 9 (43) | 8 (38) | |||
Metastasis | M0 (n=26) | 12 (46) | 0.93 | 11 (42) | 0.91 |
M1 (n=9) | 4 (44) | 4 (44) | |||
TNM stage | 1, 2 (n=18) | 8 (44) | 0.88 | 8 (44) | 0.85 |
3, 4 (n=17) | 8 (47) | 7 (41) | |||
Histology | Intestinal (n=17) | 8 (47) | 0.88 | 6 (35) | 0.38 |
Diffuse (n=18) | 8 (44) | 9 (50) | |||
Tumour site | U (n=7) | 2 (22) | 0.017 | 1 (14) | 0.0064 |
M (n=13) | 3 (23) | 3 (23) | |||
L (n=15) | 11 (73) | 11 (73) |
